# Study on the Safety, Humoral Immune Response, and Memory B Cell Response Characteristics of Sequential 9-Valent HPV Vaccination

> **NCT07530679** · NA · NOT_YET_RECRUITING · sponsor: **Jiangsu Province Centers for Disease Control and Prevention** · enrollment: 360 (estimated)

## Conditions studied

- Cervical Cancer Prevention

## Interventions

- **BIOLOGICAL:** 9-valent HPV vaccination at months 0 and 6
- **BIOLOGICAL:** 9-valent HPV vaccination at months 0 , 1 and 6

## Key facts

- **NCT ID:** NCT07530679
- **Lead sponsor:** Jiangsu Province Centers for Disease Control and Prevention
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-12
- **Primary completion:** 2027-06-30
- **Final completion:** 2028-12-31
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07530679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07530679, "Study on the Safety, Humoral Immune Response, and Memory B Cell Response Characteristics of Sequential 9-Valent HPV Vaccination". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07530679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*